Sanjay S. Shukla
Net Worth

Last updated:

What is Sanjay S. Shukla net worth?

The estimated net worth of Dr. Sanjay S. Shukla is at least $3,510,250 as of 31 May 2024. He has received compensation worth at least $3,510,250 in aTyr Pharma, Inc..

What is the salary of Sanjay S. Shukla?

Dr. Sanjay S. Shukla salary is $702,050 per year as Pres, Chief Executive Officer & Director in aTyr Pharma, Inc..

How old is Sanjay S. Shukla?

Dr. Sanjay S. Shukla is 53 years old, born in 1972.

What stocks does Sanjay S. Shukla currently own?

As insider, Dr. Sanjay S. Shukla owns shares in one company:

Company Title Shares Price per share Total value
aTyr Pharma, Inc. (LIFE) Pres, Chief Executive Officer & Director 136,548 $0 $0

What does aTyr Pharma, Inc. do?

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. The company was incorporated in 2005 and is headquartered in San Diego, California.

LIFE logo
LIFE
aTyr Pharma, Inc.

Sanjay S. Shukla insider trading

aTyr Pharma, Inc.

Dr. Sanjay S. Shukla has made 2 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he purchased 20,000 units of LIFE stock worth $36,140 on 31 May 2024.

The largest trade he's ever made was exercising 20,000 units of LIFE stock on 31 May 2024. As of 31 May 2024 he still owns at least 136,548 units of LIFE stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 20,000 $1.81 $36,140
Option
Common stock 10,375 N/A N/A
Option
Restricted Stock Unit 10,375 N/A N/A
Purchase
Common Stock 12,000 $1.18 $14,136
Purchase
Common Stock 3,000 $1.17 $3,510
Purchase
Common Stock 13,578 $1.11 $15,085
Purchase
Common Stock 1,422 $1.14 $1,618
Purchase
Common Stock 15,000 $2.02 $30,225
Option
Restricted Stock Unit 10,375 N/A N/A
Option
Common stock 10,375 N/A N/A
Purchase
Common Stock 10,000 $2.14 $21,410
Purchase
Common Stock 15,000 $2.88 $43,170
Purchase
Common Stock 5,000 $6.76 $33,805
Purchase
Common Stock 2,500 $8.58 $21,438
Purchase
Common Stock 10,000 $4.01 $40,100
Sale
Common stock 778 N/A N/A
Option
Common stock 1,785 N/A N/A
Option
Restricted Stock Unit 1,785 N/A N/A
Purchase
Common Stock 6,000 N/A N/A
Sale
Common stock 745 N/A N/A
Option
Common stock 1,786 N/A N/A
Option
Restricted Stock Unit 1,786 N/A N/A

aTyr Pharma key executives

aTyr Pharma, Inc. executives and other stock owners filed with the SEC: